Microbubble-Enabled Isolation Kit

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, November 2022
Volume 46
Issue 11
Pages: 12

Akadeum’s Life Sciences isolation kit uses microbubbles to reduce leukopak production time.

Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation Kit

Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation Kit

Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation kit is a research-use-only kit developed to address various biological and workflow challenges in large-volume cell separation workflows. The kit uses a technology combining microbubbles with a buoyancy-activated cell sorting separation tube to produce nearly two leukopaks,which are blood bags containing billions of white blood cells, in one hour.

Akadeum’s patented microbubble technology uses low-density particles to float targeted cells to the top of a sample. In addition to reducing the time necessary to produce leukopaks, the technology is also designed to promote the health and physiology of the
cells, allow for minimal handling, increase throughput, and enable less pre-processing.

Akadeum Life Sciences

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Related Content